Biomarin Pharmaceutical Inc at Leerink Global Healthcare Conference Transcript
Okay. Good morning. I'm Joe Schwartz from the SVB Leerink equity research biopharma team. It's my pleasure to host this fireside chat with Geoff Nichol, Senior Vice President, CMO and Head of Clinical Development at BioMarin. And we have a lot to talk about, so -- and a very exciting time for the company.
Why don't we just start by having you give us a quick lay of the land on your various programs and their status, and then we'll dive into Q&A?
Okay. Great. Well, certainly, I'll show a few slides. But I've been at BioMarin 3 and a bit years, and it's been a time of just -- for someone who's into late-stage clinical development like me, it's been -- I've been like a pig in the proverbial because it's been incredibly busy. We've had an enormous amount of success. And this is a time for BioMarin where the company is
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
